Skip to main content
. 2021 May 14;22(13):2257–2261. doi: 10.1002/cbic.202100113

Figure 5.

Figure 5

Profiling of representative FKBP ligands by competitive NanoBRET assays. (A) HEK293T cells stably over‐expressing FKBP12‐NLuc were treated with various FKBP ligands in the presence of 20 nM of tracer 2 b. (B) HEK293T cells stably over‐expressing FKBP51‐NLuc were treated with various FKBP ligands in the presence of 200 nM of tracer 2 c. Data points represent means±standard deviation from three independent cellular assays per concentration. Tables: Summary of the results obtained for different FKBPs. (a) compound numbers and K D values were taken from Ponplum et al.,[12] (b) compound numbers and K D values were taken from Voll et al.,[19] (c) K D values were taken from Gaali et al.,[17] (d) K D values were taken from Kozany et al.,[10] (e) K D values were determined by fluorescence polarisation assay.[12]